HOWL
Werewolf Therapeutics Inc
NASDAQ: HOWL · HEALTHCARE · BIOTECHNOLOGY
$0.68
-8.11% today
Updated 2026-04-29
Market cap
$33.05M
P/E ratio
—
P/S ratio
10.21x
EPS (TTM)
$-1.33
Dividend yield
—
52W range
$1 – $2
Volume
0.4M
Werewolf Therapeutics Inc (HOWL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-123.90%
ROA
-38.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-10.99M | — | — | — |
| 2020 | $0.00 | $-14.94M | — | — | — |
| 2021 | $4.15M | $-49.77M | -17.72% | -1,207.50% | -1,199.78% |
| 2022 | $16.40M | $-51.56M | 100.00% | -341.78% | -314.40% |
| 2023 | $19.94M | $-37.37M | 91.15% | -203.09% | -187.37% |
| 2024 | $1.89M | $-70.52M | 3.77% | -3,904.19% | -3,740.85% |
| 2025 | $0.00 | $-60.82M | — | — | — |